These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20583983)

  • 1. Targets of potential radioprotective drugs.
    Hauer-Jensen M; Kumar KS
    Curr Drug Targets; 2010 Nov; 11(11):1351. PubMed ID: 20583983
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioprotective agents to prevent cellular damage due to ionizing radiation.
    Smith TA; Kirkpatrick DR; Smith S; Smith TK; Pearson T; Kailasam A; Herrmann KZ; Schubert J; Agrawal DK
    J Transl Med; 2017 Nov; 15(1):232. PubMed ID: 29121966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Compared general pharmacologic properties of various radioprotective agents administered to rats].
    Lecomte J; Bacq ZM
    Rev Med Liege; 1968 Oct; ():Suppl 1:117+. PubMed ID: 5712315
    [No Abstract]   [Full Text] [Related]  

  • 4. Devastation in Japan. Candidate radiation drugs inch forward.
    Bhattacharjee Y
    Science; 2011 Mar; 331(6024):1505. PubMed ID: 21436412
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular hydrogen: A potential radioprotective agent.
    Hu Q; Zhou Y; Wu S; Wu W; Deng Y; Shao A
    Biomed Pharmacother; 2020 Oct; 130():110589. PubMed ID: 32763820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioprotective countermeasures for radiation injury (Review).
    Liu L; Liang Z; Ma S; Li L; Liu X
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation.
    Zivkovic Radojevic M; Milosavljevic N; Miladinovic TB; Janković S; Folic M
    Int J Radiat Biol; 2023; 99(4):594-603. PubMed ID: 35930681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amifostine as a radioprotectant.
    Gosselin TK; Mautner B
    Clin J Oncol Nurs; 2002; 6(3):175-6, 180. PubMed ID: 11998614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of radiation damages (author's transl)].
    Antoku S
    Fukuoka Igaku Zasshi; 1982 Feb; 73(2):71-5. PubMed ID: 7095724
    [No Abstract]   [Full Text] [Related]  

  • 10. [The essential questions of constructing a theory of radioprotective action on the body].
    Rozhdestvenskiĭ LM
    Radiats Biol Radioecol; 1994; 34(1):134-7. PubMed ID: 8148968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation protectants: current status and future prospects.
    Hayes DP
    Health Phys; 2006 Mar; 90(3):276; author reply 276-7. PubMed ID: 16505629
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioxidants reduce consequences of radiation exposure.
    Okunieff P; Swarts S; Keng P; Sun W; Wang W; Kim J; Yang S; Zhang H; Liu C; Williams JP; Huser AK; Zhang L
    Adv Exp Med Biol; 2008; 614():165-78. PubMed ID: 18290327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapy for the prevention and prophylactic treatment of acute radiation syndrome.
    Zenk JL
    Expert Opin Investig Drugs; 2007 Jun; 16(6):767-70. PubMed ID: 17501689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Hydrogen as a Potential Clinically Applicable Radioprotective Agent.
    Hirano SI; Ichikawa Y; Sato B; Yamamoto H; Takefuji Y; Satoh F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential utility of peptides against damage induced by ionizing radiation.
    Shaghaghi Z; Alvandi M; Nosrati S; Hadei SK
    Future Oncol; 2021 Apr; 17(10):1219-1235. PubMed ID: 33593084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further investigations on the radioprotective effectiveness of tianabol and other drugs in fractionatedly irradiated rats.
    Koćmierska-Grodzka D; Radwan J
    Strahlentherapie; 1975 Jul; 150(1):91-6. PubMed ID: 1080912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and potential effectiveness of partial-body shielding for personnel protection against ionizing radiation. USNRDL-TR-67-39.
    Shapiro ES
    Res Dev Tech Rep; 1967 Dec; ():1-49. PubMed ID: 5300786
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacological mechanisms of the radioprotective effect under whole-body conditions and the prospects of the search for radioprotectors].
    Vladimirov VG; Krasil'nikov II
    Radiats Biol Radioecol; 1994; 34(1):121-33. PubMed ID: 8148967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is there any experimental evidence for the application of radioprotective substances in radiotherapy?].
    Huber R; Teichmann B
    Arch Geschwulstforsch; 1971; 37(3):213-45. PubMed ID: 4941521
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in the development of radioprotective agents.
    Hosseinimehr SJ
    Drug Discov Today; 2007 Oct; 12(19-20):794-805. PubMed ID: 17933679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.